ANDAINJECTIONINJECTABLE
Approved
May 2012
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
CLINICAL PHARMACOLOGY Acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (e.g., some types of glaucoma), in the treatment of certain convulsive disorders (e.g., epilepsy) and in the promotion of diuresis in instances of abnormal fluid retention…